Firm Record
Lantheus Medical Imaging, Inc.
14 findings from 2 inspection documents published by regulators. Each row below says what its date means.
US FDA · Health Canada · 2026-03-09 ~ 2026-10-23
Areas cited
Published inspection documents
21 CFR sections cited in FDA inspections
Citations from 1 FDA inspection (2026-04-09) of facilities listed under this company name in FDA's inspection citation data.
| As written by FDA | Inspection | Latest inspection | |
|---|---|---|---|
| 21 CFR 211.122(d) | Label storage access limited to authorized personnel | 1 | 2026-04-09 |
| 21 CFR 211.125(a) | Strict control not exercised over labeling issued | 1 | 2026-04-09 |
| 21 CFR 211.160(b) | Scientifically sound laboratory controls | 1 | 2026-04-09 |
| 21 CFR 211.192 | Investigations of discrepancies, failures | 1 | 2026-04-09 |
| 21 CFR 211.22(d) | Procedures not in writing, fully followed | 1 | 2026-04-09 |
| 21 CFR 211.68(b) | Computer control of master formula records | 1 | 2026-04-09 |
| 21 CFR 211.84(d)(2) | Reports of Analysis (Components) | 1 | 2026-04-09 |
1 site: Lantheus Medical Imaging, Inc. (North Billerica, MA, United States) · 1 inspection
Source: FDA Data Dashboard - Inspections Citations, as of 2026-11-08. Only inspections with at least one citation are included, and a section cited more than once in one inspection counts once. Only facilities whose name and legal form match this page's documents, and that are listed in a single country, are included.
Other companies with similar findings
Other companies with findings worded closely to this company's. Only documents of the same type are compared.
A record as of publication. Check the agency's own announcements for any later corrective action.
What is included. As collected on 2026-11-15: only documents with a detail page (3 or more findings). See the firm lookup for everything.